Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy affecting an African American man: Identification of a novel 15-base pair NOTCH3 duplication

Archives of Neurology

Volumn 68, Issue 12, 2011, Pages 1584-1586

  Lee, Soo Jung ^a   Meng, He ^a   Elmadhoun, Omar ^a   Blaivas, Mila ^a   Wang, Michael Mei Hwa ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTEINE; NOTCH3 RECEPTOR;

AFRICAN AMERICAN; AGED; ARTERY DIAMETER; ARTICLE; BASE PAIRING; BRAIN DISEASE; CADASIL; CASE REPORT; CELL MEMBRANE; CONTROLLED STUDY; DEMENTIA; ELECTRON MICROSCOPY; EXON; FAMILY HISTORY; GENE; GENE DUPLICATION; GENE SEQUENCE; GENETIC SCREENING; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROLOGIC DISEASE; NOTCH3 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SMOOTH MUSCLE FIBER; UNIVERSITY HOSPITAL; WHITE MATTER ABNORMALITY;

EID: 83455225212     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.781     Document Type: Article

References (12)

1. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350(9090):1511- 1515. (Pubitemid 28036555)
2. Mazzei R, Guidetti D, Ungaro C, et al. First evidence of a pathogenic insertion in the NOTCH3 gene causing CADASIL. J Neurol Neurosurg Psychiatry. 2008; 79(1):108-110.
3. Tikka S, Mykkänen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain. 2009;132(pt 4):933-939.
4. Mazzei R, Conforti FL, Lanza PL, et al. A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL. Neurology. 2004;63 (3):561-564. (Pubitemid 39031395)
5. Dichgans M, Herzog J, Gasser T. NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology. 2001;57(9):1714-1717. (Pubitemid 33055498)
6. Joutel A, Chabriat H, Vahedi K, et al. Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL. Neurology. 2000;54(9):1874-1875. (Pubitemid 30428427)
7. Dotti MT, De Stefano N, Bianchi S, et al. A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL. Arch Neurol. 2004; 61(6):942-945. (Pubitemid 38747338)
8. Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997;56(9):947-964.
9. Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000; 105(5):597-605. (Pubitemid 30146506)
10. Smith RA, Curtain R, Ovcaric M, Tajouri L, Macmillan J, Griffiths L. Investigation of the NOTCH3 and TNFSF7 genes on C19p13 as candidates for migraine. Open Neurol J. 2008;2:1-7.
11. Mykkänen K, Savontaus ML, Juvonen V, et al. Detection of the founder effect in Finnish CADASIL families. Eur J Hum Genet. 2004;12(10):813-819. (Pubitemid 39406065)
12. Lee YC, Liu CS, Chang MH, et al. Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese. J Neurol. 2009; 256(2):249-255.